Overview Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indication: In combination with chemotherapy, with the therapy of adult people with domestically recurrent unresectable or metastatic triple-adverse breast most cancers who have not gained prior chemotherapy for metastatic disorder and whose tumours Categorical programmed mobile death-l